Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials

Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials

<i>Background:</i> Multiple myeloma is a hematological neoplasm characterized by a clonal proliferation of malignant plasma cells in the bone marrow, and is associated with high morbidity and mortality and variable survival. Positron emission tomography combined with computed tomography...

Full description

Bibliographic Details
Main Authors: Anne-Victoire Michaud-Robert, Elena Zamagni, Thomas Carlier, Clément Bailly, Bastien Jamet, Cyrille Touzeau, Philippe Moreau, Françoise Kraeber-Bodere, Cristina Nanni, Caroline Bodet-Milin
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
multiple myeloma
FDG-PET/CT
prognostic value
SUVmax
Online Access:https://www.mdpi.com/2072-6694/12/9/2532

Similar Items

Similar Items